US develops Pfizer’s COVID booster jab for 16 and 17 | Coronavirus Plague News

The CDC’s view comes amid growing fears that a new type of Omicron could lead to an epidemic in the US.

The United States is expanding its reach to COVID-19 booster jabs, as the country grapples with an increase in coronavirus infections and growing concerns about the spread of the virus. a new version of Omicron.

The U.S. Centers for Disease Control and Prevention (CDC) said Thursday that it was “strengthening its commitment to jab and encouraging anyone aged 16 and over” to receive an additional Pfizer-BioNTech shot.

The announcement came shortly after the US Food and Drug Administration (FDA) issued an emergency permit for 16- and 17-year-olds to receive the third dose of the drug. Pfizer-BioNTech vaccine if it’s been six months since they went to the last jab.

“While we do not have all the answers on the Omicron models, the sources suggest that the COVID-19 supplements contribute to enhancing and strengthening security in Omicron and other brands,” CDC chief Rochelle Walensky said in a statement.

“We know that the COVID-19 vaccine is safe and effective, and I encourage young people between the ages of 16 and 17 to be positive if they are 6 months after writing their first Pfizer vaccine.”

An estimated 4.7 million children aged 16 and 17 in the US are fully vaccinated, including more than 2.5 million adolescents over the past six months.

The move comes at a time when US officials are worried that the Omicron could start to spread rapidly during the holidays and in the colder months, when people enter homes and gather in groups.

But more and more Delta species are still causing almost all COVID-19 infections in the US, while the CDC has identified less than 100 cases of Omicron in the country so far. Areas where households have relocated during the winter have seen a dramatic increase in new cases, now about 120,000 per day.

Earlier this month, US President Joe Biden he announced several ways to deal with the recurrence of the virus, including access to booster jabs, free home coronavirus tests, and other travel restrictions.

Disrupting the idea of ​​developing physical activity for 16- and 17-year-olds and the fact that the Pfizer-BioNTech shot – as well as a similar vaccine developed by Moderna – was linked to a rare condition called myocarditis – a type of heart attack that is more common in boys and young men.

But the FDA says the rise in COVID-19 cases means the benefits of extras far outweighed the potential risk, especially since coronavirus alone can lead to severe heart failure.

The Pfizer-BioNTech vaccine is the only option in the US for anyone under the age of 18 [Brian Snyder/Reuters]

Everything American officials they are currently eligible to launch three US-approved COVID-19 vaccines.

The Pfizer-BioNTech vaccine is the only option for anyone under the age of 18, whether the first vaccine or used as a supplement. It is unknown at this time what he will do after leaving the post.

Vaccination for children as small as five launched last month, using Pfizer-BioNTech special, low-cost special shots. By this week, about 5 million children between the ages of 5 and 11 had received the first dose.

“Vaccine exercise increases immunity and contributes significantly to the protection of COVID-19 in all the groups that have studied so far,” BioNTech CEO Ugur Sahin said in a statement.